Total planned funding: $297,271,900
Allocations
Countries/Regions
Eswatini | $297,271,900 |
Organizational Types
Private Contractor | $84,712,017 |
University | $53,075,573 |
NGO | $46,931,494 |
Unknown | $44,470,843 |
Own Agency | $37,390,002 |
FBO | $13,230,009 |
Host Country Government Agency | $9,914,978 |
Multi-lateral Agency | $6,379,130 |
Other USG Agency | $1,167,854 |
Program Areas
Care | $93,354,658 |
Treatment | $81,337,685 |
Prevention | $53,152,982 |
Governance and Systems | $24,737,082 |
Testing | $24,020,605 |
Management and Operations | $20,668,888 |
Budget Codes
HTXS: Treatment: Adult Treatment | $65,740,636 |
HBHC: Care: Adult Care and Support | $39,777,903 |
HKID: Care: Orphans and Vulnerable Children | $33,935,880 |
HVCT: Testing: HIV Testing and Counseling | $24,020,605 |
HVOP: Sexual Prevention: Other Sexual Prevention | $22,968,133 |
HVMS: Management and Operations | $20,668,888 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,788,763 |
HVTB: Care: TB/HIV | $12,004,797 |
OHSS: Health Systems Strengthening | $11,668,492 |
HVSI: Strategic Information | $9,065,379 |
HTXD: Treatment: ARV Drugs | $9,009,456 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,277,548 |
PDCS: Care: Pediatric Care and Support | $7,636,078 |
PDTX: Treatment: Pediatric Treatment | $6,587,593 |
HLAB: Laboratory Infrastructure | $4,003,211 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,313,567 |
HMBL: Biomedical Prevention: Blood Safety | $804,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$43,692,197
Countries/Regions
Pact, Inc.:
$36,862,607
Countries/Regions
Not Available:
$26,160,977
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions